Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has entered into a Memorandum of Understanding (“MOU”… Read More

Unique scientific approach lends more credibility and increases consumer confidence Huge potential for cannabis to replace opioids as analgesics Strategic partnerships position Veritas stro… Read More

Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce the results of its… Read More

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") is pleased to announce that it h… Read More

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announce that it has… Read More

Each week, DCN will curate a rundown of startup, tech, and innovation news in the cannabis industry for its new series, DCN Micro News. February 11th, 2019 Canadian Cannabis… Read More

Veritas meldet verbindlichen Aktienkaufvertrag mit Leis Industries Limited zwecks Verkaufs von Sechelt Organic Marijuana 14. November 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE:… Read More

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased… Read More

VANCOUVER, British Columbia, Nov. 20, 2017 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) annou… Read More